💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Oxford Immunotec Global PLC (OXFD)
« Back to company indexOXFD Chatter Timeline
Stock Ticker for OXFD
Most Active Tweeters for OXFD
| User | Tweets |
|---|---|
| @Tradingheavy | 1 |
Recent Tweets for OXFD
 |
@Tradingheavy ? Buy Alert $29,935,612 or 5.3% worth of $OXFD - Oxford Immunotec Global PLC shares were purchased or held on Feb 2… https://t.co/6AagOmIMMh April 19th 2021, 10:04pm |
|
@Tradingheavy ? Buy Alert $23,429,612 or 5.2% worth of $OXFD - Oxford Immunotec Global PLC shares were purchased or held on Dec 3… https://t.co/ni0RsyAMFZ April 3rd 2021, 3:04pm |
|
@Tradingheavy ? Buy Alert $49,110,028 or 8.6% worth of $OXFD - Oxford Immunotec Global PLC shares were purchased or held on Dec 3… https://t.co/qQiWshU7Np March 25th 2021, 1:03pm |
 |
@InsiderAlerts4U $OXFD: New Insider Filing on Oxford Immunotec Global PLC's Director ANDREW SCOTT WALTON: https://t.co/wTGodUUVCk March 13th 2021, 12:03pm |
|
@InsiderAlerts4U $OXFD: New Insider Filing on Oxford Immunotec Global PLC's Director RICHARD A SANDBERG: https://t.co/WOe9vyBbVu March 13th 2021, 10:03am |
|
@InsiderAlerts4U $OXFD: New Insider Filing on Oxford Immunotec Global PLC's Chief Executive Officer PETER WRIGHTON-SMITH: https://t.co/V3Mub6VaK9 March 13th 2021, 10:03am |
|
@InsiderAlerts4U $OXFD: New Insider Filing on Oxford Immunotec Global PLC's Chief Financial Officer MATTHEW T E MCLAUGHLIN: https://t.co/bnXeJDkNKo March 13th 2021, 9:03am |
 |
@newsfilterio $89,782.00 of shares sold by Tobin James R (Director), reported in a new form 4 filed with the SEC $OXFD https://t.co/qDxuusfaHv March 13th 2021, 6:03am |
|
@newsfilterio $89,782.00 of shares sold by Andrews Ronald Asbury (Director), reported in a new form 4 filed with the SEC $OXFD https://t.co/F77SfVFV5J March 13th 2021, 6:03am |
|
@newsfilterio $89,782.00 of shares sold by Walton Andrew Scott (Director), reported in a new form 4 filed with the SEC $OXFD https://t.co/gHO9OmbA3m March 13th 2021, 6:03am |
|
@newsfilterio $177,782.00 of shares sold by Balthrop Patrick J (Director), reported in a new form 4 filed with the SEC $OXFD https://t.co/h8JCfTGxGu March 13th 2021, 6:03am |
|
@newsfilterio $611,710.00 of shares sold by Randall Patricia (Director), reported in a new form 4 filed with the SEC $OXFD https://t.co/PjxWbk8qzE March 13th 2021, 6:03am |
|
@newsfilterio $89,782.00 of shares sold by Klausner Mark R. (Director), reported in a new form 4 filed with the SEC $OXFD https://t.co/XwwWkLvZrU March 13th 2021, 6:03am |
|
@newsfilterio $89,782.00 of shares sold by Sandberg Richard A (Director), reported in a new form 4 filed with the SEC $OXFD https://t.co/JYPN4dg1aw March 13th 2021, 6:03am |
|
@newsfilterio $89,782.00 of shares sold by Rosenman Herm (Director), reported in a new form 4 filed with the SEC $OXFD https://t.co/ABkZp2KgHS March 13th 2021, 6:03am |
|
@InsiderAlerts4U $OXFD: New Insider Filing on Oxford Immunotec Global PLC's Director RONALD ASBURY ANDREWS: https://t.co/rhCVLOdEtF March 13th 2021, 6:03am |
|
@InsiderAlerts4U $OXFD: New Insider Filing on Oxford Immunotec Global PLC's General Counsel JANET LOUISE KIDD: https://t.co/LM6isCKant March 13th 2021, 5:03am |
|
@InsiderAlerts4U $OXFD: New Insider Filing on Oxford Immunotec Global PLC's Director HERM ROSENMAN: https://t.co/mJDYo8zT25 March 13th 2021, 2:03am |
|
@InsiderAlerts4U $OXFD: New Insider Filing on Oxford Immunotec Global PLC's Director JAMES R TOBIN: https://t.co/rB4tDJNh1c March 13th 2021, 1:03am |
|
@InsiderAlerts4U $OXFD: New Insider Filing on Oxford Immunotec Global PLC's Director MARK R. KLAUSNER: https://t.co/PiQ3mQXzqS March 13th 2021, 12:03am |
|
@InsiderAlerts4U $OXFD: New Insider Filing on Oxford Immunotec Global PLC's Director PATRICK J BALTHROP: https://t.co/6eABX1t8Lv March 12th 2021, 11:03pm |
|
@InsiderAlerts4U $OXFD: New Insider Filing on Oxford Immunotec Global PLC's Director PATRICIA RANDALL: https://t.co/EtYrsjhoxG March 12th 2021, 9:03pm |
 |
@fintel_io $OXFD / Oxford Immunotec Global files form S-8 POS https://t.co/14il8MgDjN March 12th 2021, 9:03pm |
 |
@shortablestocks Zero shares available to short currently in $OXFD. https://t.co/Ai25s1FAaw March 9th 2021, 4:03pm |
 |
@InsiderForms $OXFD Glazer Capital, LLC has filed Form SC 13G with SEC. Reporting 5.3% Ownership. https://t.co/t5CkFUZh7T March 8th 2021, 10:03pm |
 |
@EdgarInsider SEC Form 8-K [Press/News Current Report] filed by $OXFD Oxford Immunotec Global PLC https://t.co/kbsYMMslIm March 8th 2021, 9:03pm |
 |
@FlashAlert_me $OXFD [15s. delayed] filed form 25-NSE on March 08, 09:24:11 https://t.co/uizQpdW35M March 8th 2021, 2:03pm |
 |
@LargeVoidBot $OXFD Halt - Additional Information Requested by NASDAQ. Halt time: 03/05/2021 19:50:05. March 8th 2021, 12:03pm |
|
@InsiderForms $OXFD Trading Halted for Oxford Immunotec Global PLC (OXFD). Halt Reason: ADDITIONAL INFORMATION REQUESTED BY NASDA… https://t.co/YJmB9j2CnP March 8th 2021, 11:03am |
 |
@LiquidityNews Trading Halted for $OXFD Oxford Immunotec Global PLC | at 19:50:05 ET on NASDAQ | Halt - Additional Information Re… https://t.co/MJhrA9FVuJ March 6th 2021, 12:03am |
 |
@HaltTrade $OXFD trade halt (T12) was alerted within seconds to our Members with the halt price of $21.99 and volume of 812.00… https://t.co/m8imtnHrKH March 6th 2021, 12:03am |
 |
@TradeWithAlerts Large Print $OXFD Size: 122545 Price: 21.975 Time: 945 Amount: $2,692,926.38 March 5th 2021, 2:03pm |
 |
@sbwcws Oxford Immunotec submits EUA request to FDA for T-Spot Covid test $OXFD March 4th 2021, 10:03pm |
 |
@Briefingcom $OXFD: Oxford Immunotec files EUA request to the FDA for T-SPOT.COVID test https://t.co/YhA1ZtGqa3 March 4th 2021, 9:03pm |
 |
@StockNewsBot2 $OXFD Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test fo… https://t.co/5zfXLLiKbu March 4th 2021, 7:03pm |
 |
@otcdynamics $OXFD Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test fo… https://t.co/U9GdZQ84IP March 4th 2021, 7:03pm |
 |
@hmgnzlz RT @Manpree31938145: $OXFD Oxford announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for q… March 4th 2021, 7:03pm |
 |
@Manpree31938145 $OXFD Oxford announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended fo… https://t.co/HQYb18Kehr March 4th 2021, 7:03pm |
 |
@stock_titan $OXFD Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test fo… https://t.co/1U7NkNu58M March 4th 2021, 7:03pm |
 |
@AlertTrade VOLUME RADAR: $OXFD Oxford Immunotec Global Plc OR https://t.co/02YY08tDCK ? TradeIdeas via ? https://t.co/zWAorAmh9Y March 4th 2021, 3:03pm |
|
@TradeWithAlerts Large Print $OXFD Size: 250000 Price: 21.97 Time: 944 Amount: $5,492,500.00 March 4th 2021, 2:03pm |
|
@TradeWithAlerts Large Print $OXFD Size: 140115 Price: 21.97 Time: 1600 Amount: $3,078,326.55 March 2nd 2021, 9:03pm |
|
@EdgarInsider Alert [Press/News Current Report] / Form 8-K filed with the SEC $OXFD Oxford Immunotec Global PLC https://t.co/DElVvA0lo4 February 26th 2021, 11:02pm |
 |
@ChartMill A Current Ratio of 15.96 indicates that $OXFD has no problem at all paying its short term obligations.… https://t.co/FJaRAPwu89 February 19th 2021, 5:02pm |
|
@InsiderForms $OXFD Consonance Capital Management LP has filed Form SC 13G/A with SEC. Reporting 0% Ownership. https://t.co/t5CkFUHFJj February 17th 2021, 8:02pm |
|
@FlashAlert_me $OXFD [15s. delayed] filed form SC 13G/A on February 17, 15:14:15 https://t.co/S4gJVYKIfU February 17th 2021, 8:02pm |
|
@InsiderForms $OXFD Endurant Capital Management LP has filed Form SC 13G/A with SEC. Reporting 0.00% Ownership. https://t.co/t5CkFUHFJj February 17th 2021, 2:02pm |
 |
@StockTexts $OXFD Oxford Immunotec Global PLC SEC Filing: Form SC 13G/A https://t.co/EXII3VO5w5 February 17th 2021, 2:02pm |
|
@Tradingheavy ? Buy Alert $25,623,515 or 4.6% worth of $OXFD - Oxford Immunotec Global PLC shares were purchased or held on Jan 2… https://t.co/gU1VElBnt5 February 16th 2021, 6:02pm |
|
@InsiderForms $OXFD Polar Capital Holdings Plc has filed Form SC 13G/A with SEC. Reporting 9.89% Ownership. https://t.co/t5CkFUZh7T February 16th 2021, 12:02pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
